Express Scripts (ESRX) weekly volatility increases into Q2 and outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
Go back to Express Scripts (ESRX) weekly volatility increases into Q2 and outlook
July 26, 2016 9:22 AM EDT
Jefferies maintained a Buy rating on Express Scripts (NASDAQ: ESRX), and cut the price target to $88.00 (from $98.00), following the company's 2Q earnings report. ESRX's volumes were slightly below expectations at 315MM, but in-line results should offset this 1% shortfall.
Analyst Brian Tanquilut commented,... More
July 26, 2016 6:54 AM EDT
FBR Capital reiterated a Market Perform rating and $75.00 price target on Express Scripts (NASDAQ: ESRX) following the company's 2Q earnings report. ESRX reported revenue of $25.3 billion, slightly below consensus estimates of $25.4 billion. Adjusted EPS grew 9.3% to $1.57.
Analyst Steven Halper commented, "After the close on July 25, Express... More
July 25, 2016 4:02 PM EDT
Express Scripts (NASDAQ: ESRX) reported Q2 EPS of $1.57, in-line with the analyst estimate of $1.57. Revenue for the quarter came in at $25.2 billion versus the consensus estimate of $25.42 billion.
GUIDANCE:
Express Scripts sees FY2016 EPS of $6.33-$6.43, versus prior guidance of... More
